Related Experiment Videos
Emerging issues with bisphosphonates
1Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand. ireid@auckland.ac.nz
Abstract:
Bisphosphonates are the most commonly used agents in the management of metabolic bones diseases. Despite their established therapeutic value, a number of points of uncertainty remain, particularly in connection with their optimal long-term use. It is likely that definitive clinical trial data will not become available to resolve these questions, so careful clinical observation and caution are needed in patients who require treatment over periods of more than 10 years.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Chronic Kidney Disease II: Clinical Manifestations
Osteoclasts in Bone Remodeling
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...